Side-Branch Balloon Angioplasty
Cross-source consensus on Side-Branch Balloon Angioplasty from 1 sources and 4 claims.
1 sources · 4 claims
Benefits
Comparisons
Evidence quality
Highlighted claims
- The BA comparison was heavily influenced by the DCB-BIF trial. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- Side-branch balloon angioplasty was a comparator strategy to hybrid DCB in the review. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- Myocardial infarction was lower with hybrid DCB than with side-branch BA in pooled analysis. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis
- Target lesion revascularisation did not significantly differ between hybrid DCB and side-branch BA in pooled analysis. — Hybrid drug-coated balloon strategy for coronary bifurcation lesions: a systematic review and meta-analysis